Elizabeth Nabel
Cardiovascular Disease Boston, MA Medical Doctor
NPI 1417260696 CMS profile 972971
75 Francis St, Pb4 Room 408 (Hospital Administration), Boston, MA 02115
General payments
$2,246,241
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Elizabeth Nabel of Boston, MA is reported in the CMS Open Payments database as having received $2,246,241 across 344 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $89,321 | 7 | |
| 2024 | General | $317,549 | 68 | |
| 2023 | General | $126,386 | 79 | |
| 2022 | General | $471,266 | 55 | |
| 2021 | General | $443,705 | 61 | |
| 2020 | General | $390,290 | 26 | |
| 2019 | General | $407,724 | 48 |
Beside peers
- Elizabeth Nabel
- Cardiovascular Disease median
- Middle half of Cardiovascular Disease
- National median
In program year 2025, general payments to Elizabeth Nabel were reported at $89,321. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.
Show as a table
| Year | Elizabeth Nabel | Cardiovascular Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $407,724 | $450 | $127–$1,392 | $163 |
| 2020 | $390,290 | $242 | $77–$751 | $114 |
| 2021 | $443,705 | $335 | $101–$1,037 | $132 |
| 2022 | $471,266 | $395 | $121–$1,211 | $149 |
| 2023 | $126,386 | $443 | $136–$1,283 | $160 |
| 2024 | $317,549 | $450 | $136–$1,323 | $164 |
| 2025 | $89,321 | $432 | $132–$1,252 | $169 |
Breakdown
Records
344 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Cardiovascular Disease in Massachusetts
Marc Sabatine
Cardiovascular Disease · Boston, MA
Kenneth Rosenfield
Cardiovascular Disease · Boston, MA
Kevin Croce
Cardiovascular Disease · Chestnut Hill, MA
James Januzzi
Cardiovascular Disease · Boston, MA
Muthiah Vaduganathan
Cardiovascular Disease · Boston, MA
Joseph Loscalzo
Cardiovascular Disease · Boston, MA
Related records
Cardiovascular Disease in Massachusetts
Practitioners in the same specialty and state, ranked by reported value.
All Cardiovascular Disease
Everyone recorded under this specialty, nationwide.
Doctors in Massachusetts
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.